If You Buy Fluor (FLR) Stock Today, Here's the Bull Case for the Next 5 Years

Fluor’s backlog reached $25.5 billion at the end of 2025, with over 80% now in reimbursable contracts that should make earnings more predictable. Analysts expect the company to return to profitability in 2026 and grow EPS at a 16% CAGR through 2028, supported by secular demand in cloud, AI, nuclear, infrastructure, and government projects. Offsetting that is a one-time legal payment to Santos, ongoing execution risk, and continued NuScale stake sales and buybacks that may add volatility.

Analysis

FLR’s setup is less about headline growth and more about a cleaner earnings conversion regime. The market is likely still underappreciating how a backlog mix shift toward reimbursable work compresses volatility in future quarters: near-term margin optics look worse, but the probability distribution of earnings narrows, which should support a structurally higher multiple once investors trust the cadence. That matters because construction names usually rerate not on peak EPS, but on lower dispersion and fewer surprise write-downs.

The second-order winner is the broader power and industrial capex ecosystem. If AI-driven load growth forces utilities, hyperscalers, and nuclear developers to commit earlier to multi-year builds, FLR becomes a toll collector on incremental project starts, while more disciplined execution should also reduce bidding discounts across peers. SMR is the optionality leg, but the more important effect is that successful SMR commercialization would expand the addressable project funnel for engineers, EPC vendors, and component suppliers, even if FLR monetizes it only indirectly through portfolio gains and future contracting activity.

The main risk is timing mismatch: the next 2-4 quarters could still feature lumpy results if client spending defers or if another project issue forces the market to revisit execution credibility. In other words, the stock may be cheap on 2027-2028 earnings but not obviously cheap on near-term reported numbers, so a drawdown is possible before the rerate arrives. A sustained pullback in NuScale could also remove an important financing and buyback engine, making the equity story more levered to pure operating improvement.

Consensus seems to be treating FLR as a gradual compounder, but the market may be missing the asymmetry between downside from one-off execution noise and upside from even modest multiple expansion. If management delivers just enough consistency to keep buybacks active while backlog stays above $25B, the stock can rerate before the full AI/infrastructure capex cycle shows up in revenue. The key question is not whether earnings grow, but whether investors will pay for lower quality-adjusted risk after years of proving they can’t.

Key Decisions for Investors

• Long FLR on any 5-8% pullback over the next 1-2 months; target a 12-18 month hold with upside to a higher mid-teens P/E if execution remains clean, but cut if another project charge reopens credibility risk.
• Pair trade: long FLR / short a higher-beta infrastructure contractor with more fixed-price exposure for 6-12 months; the spread should favor the name with improving backlog quality and less earnings volatility.
• Buy FLR Jan-2027 calls or call spreads rather than common if using event-driven timing; this captures the 2026 profitability inflection while limiting downside if another quarter of noise delays rerating.
• Maintain a small long SMR as a convexity hedge to FLR earnings volatility; if nuclear buildout sentiment accelerates, the mark-to-market on the stake can partially offset weak operating quarters.
• Avoid chasing after a strong quarter unless backlog quality and buyback cadence both improve; the stock’s best entry is likely on an execution scare that does not impair the underlying contract mix.